Validity of adjuvant! Online program in older patients with breast cancer: A population-based study

The Lancet Oncology

Volumn 15, Issue 7, 2014, Pages 722-729

  De Glas, Nienke A ^a   Van de Water, Willemien ^a   Engelhardt, Ellen G ^a   Bastiaannet, Esther ^a   De Craen, Anton J M ^a   Kroep, Judith R ^a   Putter, Hein ^a   Stiggelbout, Anne M ^a   Weijl, Nir I ^b   Van de Velde, Cornelis J H ^a   Portielje, Johanneke E A ^c   Liefers, Gerrit Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGE; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; COMORBIDITY; COMPUTER PROGRAM; FEMALE; FOLLOW UP; HUMAN; INFORMATION SERVICE; INSTRUMENT VALIDATION; MAJOR CLINICAL STUDY; MASTECTOMY; MEASUREMENT ACCURACY; NETHERLANDS; OVERALL SURVIVAL; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; INTERNET; ROC CURVE;

EID: 84901470507     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70200-1     Document Type: Article

References (33)

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), 1617.
2. van de Water W, Markopoulos C, van de Velde CJ, et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012, 307:590-597.
3. Berry SD, Ngo L, Samelson EJ, Kiel DP Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 2010, 58:783-787.
4. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001, 19:980-991.
5. Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005, 23:2716-2725.
6. Mook S, Schmidt MK, Rutgers EJ, et al. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. Lancet Oncol 2009, 10:1070-1076.
7. Hajage D, de Rycke Y, Bollet M, et al. External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement. PLoS One 2011, 6:e27446.
8. Campbell HE, Taylor MA, Harris AL, Gray AM An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom. Br J Cancer 2009, 101:1074-1084.
9. Yao-Lung K, Dar-Ren C, Tsai-Wang C Accuracy validation of adjuvant! online in Taiwanese breast cancer patients-a 10-year analysis. BMC Med Inform Decis Mak 2012, 12:108.
10. Bhoo-Pathy N, Yip CH, Hartman M, et al. Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. Eur J Cancer 2012, 48:982-989.
11. Engelhardt EG, Garvelink MM, de Haes JH, et al. Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models. J Clin Oncol 2013, 32:238-250.
12. NABON. Richtlijn Mammacarcinoom versie 2.0. 13-2-2012. [in Dutch] (accessed April 10, 2014).
13. Wildiers H, Kunkler I, Biganzoli L, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007, 8:1101-1115.
14. Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012, 13:e148-e160.
15. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012, 380:37-43.
16. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011, 103:1101-1111.
17. Kendal WS Dying with cancer: the influence of age, comorbidity, and cancer site. Cancer 2008, 112:1354-1362.
18. de Glas NA, Kiderlen M, Bastiaannet E, et al. Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat 2013, 138:561-569.
19. Kiderlen M, de Glas NA, Bastiaannet E, et al. Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis. Ann Oncol 2013, 24:3011-3016.
20. The ICD-10 classification of mental and behavioural disorders 1992, 10:1-267. WHO, World Health Organization, Geneva.
21. Jager KJ, van Dijk PC, Zoccali C, Dekker FW The analysis of survival data: the Kaplan-Meier method. Kidney Int 2008, 74:560-565.
22. Mell LK, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ Predictors of competing mortality in early breast cancer. Cancer 2010, 116:5365-5373.
23. Putter H, Fiocco M, Geskus RB Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007, 26:2389-2430.
24. Crowson CS, Atkinson EJ, Therneau TM Assessing calibration of prognostic risk scores. Stat Methods Med Res 2014, published online April 7. 10.1177/0962280213497434.
25. Heagerty PJ, Zheng Y Survival model predictive accuracy and ROC curves. Biometrics 2005, 61:92-105.
26. Akobeng AK Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 2007, 96:644-647.
27. Bastiaannet E, Liefers GJ, de Craen AJ, et al. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat 2010, 124:801-807.
28. Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 2011, 26:783-790.
29. van de Water W, Kiderlen M, Bastiaannet E, et al. External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. J Natl Cancer Inst 2014, 106:dju051.
30. Brain E, Baffert S, Bonnefoi H, et al. ASTER 70s: Benefit of adjuvant chemotherapy for oestrogen receptor-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial. Cancer Research 2012, 72:OT3-3-OT310.
31. Hu CY, Xing Y, Cormier JN, Chang GJ Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer 2013, 119:1900-1907.
32. Goldoni CA, Bonora K, Ciatto S, et al. Misclassification of breast cancer as cause of death in a service screening area. Cancer Causes Control 2009, 20:533-538.
33. van de Water W, Bastiaannet E, Dekkers OM, et al. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg 2012, 99:813-820.